New Products In Brief
This article was originally published in The Gray Sheet
Executive SummarySequenom’s Down syndrome test
You may also be interested in...
A drug-eluting stent and prostate cancer assay are among newly approved devices.
InSightec submits ExAblate PMA to treat pain caused by bone metastases. AngioDynamics initiates NanoKnife software recall. Sequenom raises $62 million in secondary stock offering. More news briefs.